Teva Recalls Drugs With Probable Carcinogen

December 7, 2018

Teva Pharmaceuticals has recalled two drugs used to treat high blood pressure due to the presence of a probable human carcinogen, N-nitroso-diethylamine (NDEA).

The recall affects all lots of:


Pharmacies can contact Teva by phone at 888-838-2872, or email atĀ

View the full list of recalled products in the FDA press release.